Back to Rankings

CFBK

CF BanksharesB
Nasdaq / Banks
Last Price
At close
2026-06-02
View Chart

AI scenario view

RankAlpha Sentiment CodexPost-earnings T+3
B+
Bull case
25%
Probability
Target price
$31.00
+7.6% vs current
Most likely
B
Base case
45%
Probability
Target price
$28.00
-2.8% vs current
B-
Bear case
30%
Probability
Target price
$23.00
-20.2% vs current

AI sentiment snapshot

Latest data as of 2026-05-16
Recent news sentiment (30D)
+16.9
Positive
Company
+23.6
Positive
Macro
+17.9
Positive
Pulse
-34.8
Negative
Sentiment proxy
+43.3
Score

AI commentary

This was a cautious post-earnings follow-up. The queue referenced May 13, 2026, but the company’s actual Q1 earnings release and 8-K were filed on May 5, 2026. Market reaction was mildly negative at first: CFBK closed at $27.77 on May 4, $27.35 on May 5, and $26.75 on May 6, then recovered to $27.21 by May 15, suggesting the print did not trigger a decisive rerating. Trusted-news and analyst-revision evidence after the release was limited in this run, so sentiment remains monitoring-oriented rather than strongly bullish or capitulative.

RankAlpha Sentiment Codex - 2026-05-16
Open post-earnings memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-05-16eventQ1 earnings reset now hinges on whether late-quarter loan growth converts into cleaner Q2 revenueMedium impact

CF Bankshares reported Q1 2026 net income of $5.0 million, core commercial net loan growth of $45 million, and management said heavier fundings arrived late in the quarter, with expected interest-income benefit beginning in Q2. The same release also disclosed a $5.0 million non-core loan moved to nonaccrual, cutting Q1 interest income by $528,000 and reducing NIM by 11 bps, so the next read-through is whether growth carries into revenue without another credit drag [#8-K-2026-05-05] [#10-Q-2026-05-11].

2026-08-15catalystCredit normalization is still not fully proven after the added nonaccrual loanHigh impact

Asset-quality metrics weakened in Q1 as nonaccrual loans rose to $20.3 million from $15.3 million at year-end, loans 30 days or more past due rose to $17.5 million from $12.9 million, and the allowance ratio increased to 1.05% from 1.01%. Management framed the new problem loan as a non-core non-customer exposure, but another reserve or nonaccrual surprise would likely pressure a low-coverage micro-cap bank multiple [#8-K-2026-05-05] [#10-Q-2026-05-11].

2026-12-31catalystFunding-cost relief and fee initiatives can support a gradual earnings recovery if execution holdsHigh impact

Management highlighted a 34 bps year-over-year and 15 bps sequential decline in cost of funds, a 23% increase in noninterest income, and continued treasury-management and swap-fee initiatives. If those trends persist while commercial banking teams add full C&I relationships, CFBK has a plausible but still unproven path to better profitability and scale [#8-K-2026-05-05].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-05-16 • Updated nightlySource: Internal modelMethodology